DOI QR코드

DOI QR Code

Feasibility of a deep learning-based diagnostic platform to evaluate lower urinary tract disorders in men using simple uroflowmetry

  • Seokhwan Bang (Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Sokhib Tukhtaev (Medical AI Research Center, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kwang Jin Ko (Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Deok Hyun Han (Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Minki Baek (Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Hwang Gyun Jeon (Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Baek Hwan Cho (Medical AI Research Center, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kyu-Sung Lee (Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2021.11.09
  • Accepted : 2022.02.24
  • Published : 20220500

Abstract

Purpose To diagnose lower urinary tract symptoms (LUTS) in a noninvasive manner, we created a prediction model for bladder outlet obstruction (BOO) and detrusor underactivity (DUA) using simple uroflowmetry. In this study, we used deep learning to analyze simple uroflowmetry. Materials and Methods We performed a retrospective review of 4,835 male patients aged ≥40 years who underwent a urodynamic study at a single center. We excluded patients with a disease or a history of surgery that could affect LUTS. A total of 1,792 patients were included in the study. We extracted a simple uroflowmetry graph automatically using the ABBYY Flexicapture® image capture program (ABBYY, Moscow, Russia). We applied a convolutional neural network (CNN), a deep learning method to predict DUA and BOO. A 5-fold cross-validation average value of the area under the receiver operating characteristic (AUROC) curve was chosen as an evaluation metric. When it comes to binary classification, this metric provides a richer measure of classification performance. Additionally, we provided the corresponding average precision-recall (PR) curves. Results Among the 1,792 patients, 482 (26.90%) had BOO, and 893 (49.83%) had DUA. The average AUROC scores of DUA and BOO, which were measured using 5-fold cross-validation, were 73.30% (mean average precision [mAP]=0.70) and 72.23% (mAP=0.45), respectively. Conclusions Our study suggests that it is possible to differentiate DUA from non-DUA and BOO from non-BOO using a simple uroflowmetry graph with a fine-tuned VGG16, which is a well-known CNN model.

Keywords

Acknowledgement

This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (Ministry of Science and ICT) (No. 2017R1E1A1A01077487, 2020R1F1A1070952).